SPYD vs VHT
SPDR Portfolio S&P 500 High Dividend ETF vs Vanguard Health Care ETF
- • SPYD has the lower expense ratio at 0.07% vs 0.09% for VHT.
- • SPYD pays a higher dividend yield (4.26%).
Side-by-side metrics
| Metric | SPYD | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.09% |
Dividend yield Trailing 12-month yield. | 4.26% | 1.58% |
AUM Assets under management — bigger funds are typically more liquid. | $7.37B | $20.39B |
YTD return | 13.25% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.64 | 0.57 |
P/E ratio | 17.38 | 26.46 |
Last price | $47.94 | $306.54 |
Inception | — | — |
Issuer | State Street | Vanguard |
SPYD top holdings
| IRM | Iron Mountain Inc | 1.61% |
| BEN | Franklin Resources Inc | 1.56% |
| CVS | CVS Health Corp | 1.51% |
| HST | Host Hotels & Resorts Inc | 1.51% |
| EIX | Edison International | 1.47% |
| TGT | Target Corp | 1.47% |
| APA | APA Corp | 1.46% |
| VTRS | Viatris Inc | 1.45% |
| KIM | Kimco Realty Corp | 1.44% |
| SPG | Simon Property Group Inc | 1.44% |
VHT top holdings
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
About SPYD
SPYD (SPDR Portfolio S&P 500 High Dividend ETF) is Top 80 highest-yielding S&P 500 stocks. Managed by State Street, the fund carries $7.4B in assets under management, an expense ratio of 0.07%, a dividend yield of 4.26%. Its largest holding is Iron Mountain Inc (IRM), which represents 1.6% of the portfolio. Real Estate is the fund's largest sector exposure at 27.3%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.